Now showing items 1-1 of 1
Safety and efficacy of megakaryocytes induced from hematopoietic stem cells in murine and nonhuman primate models
(Stem Cells Translational Medicine, 2016)
Because of a lack of platelet supply and a U.S. Food and Drug Administration-approved platelet growth factor, megakaryocytes have emerged as an effective substitute for alleviating thrombocytopenia. Here, we report the ...